WELL Health Technologies Corp. (TSX:WELL)
Canada · Delayed Price · Currency is CAD 4.590
+0.210 (4.79%)
Jun 1, 2026, 4:00 PM EST
WELL Health Technologies Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 1,474 | 1,400 | 919.69 | 776.05 | 569.14 | 302.32 | |
Revenue Growth (YoY) | 55.38% | 52.24% | 18.51% | 36.36% | 88.25% | 501.76% |
Cost of Revenue | 809.76 | 781.34 | 556.68 | 403.79 | 265.85 | 148.63 |
Gross Profit | 664.54 | 618.84 | 363.01 | 372.27 | 303.29 | 153.7 |
Selling, General & Admin | 439.96 | 409.69 | 306.2 | 250.82 | 199.62 | 102.51 |
Depreciation & Amortization Expenses | 99.79 | 93.76 | 72.31 | 60.77 | 55.2 | 38.71 |
Other Operating Expenses | 39.79 | 36.91 | 14.7 | 25.53 | 25.15 | 25.76 |
Total Operating Expenses | 579.54 | 540.36 | 393.21 | 337.11 | 279.98 | 166.98 |
Operating Income | 85 | 78.49 | -30.2 | 35.16 | 23.31 | -13.29 |
Interest Income | 0.56 | -1.04 | -3.07 | 0.39 | 0.25 | 0.35 |
Interest Expense | -46.47 | -57.88 | -37.62 | -33.6 | -25.29 | -9.01 |
Other Non-Operating Income (Expense) | 2.55 | -14.26 | 79.87 | 17.56 | 19.25 | -3.54 |
Total Non-Operating Income (Expense) | -43.36 | -73.18 | 39.19 | -15.66 | -5.79 | -12.2 |
Pretax Income | 41.64 | 5.31 | 8.99 | 19.5 | 17.53 | -25.49 |
Provision for Income Taxes | 0.62 | 0.85 | -20.1 | 2.86 | -1.15 | 5.8 |
Net Income | 26.83 | -7.36 | 32.61 | 0.08 | 1.37 | -44.18 |
Minority Interest in Earnings | 14.19 | 11.82 | -3.51 | 16.56 | 17.31 | 12.89 |
Net Income to Common | 26.83 | -7.36 | 32.61 | 0.08 | 1.37 | -44.18 |
Net Income Growth | - | - | 39667.07% | -94.01% | - | - |
Shares Outstanding (Basic) | 254 | 253 | 247 | 237 | 221 | 191 |
Shares Outstanding (Diluted) | 254 | 253 | 255 | 237 | 221 | 191 |
Shares Change (YoY) | -0.02% | -0.73% | 7.66% | 7.18% | 15.61% | 42.56% |
EPS (Basic) | 0.11 | -0.03 | 0.13 | - | - | -0.23 |
EPS (Diluted) | 0.11 | -0.03 | 0.13 | - | - | -0.23 |
Shares Outstanding | 254.87 | 253.99 | 249.09 | 241.43 | 231.05 | 209.15 |
Free Cash Flow | 82.87 | 94.02 | -6.7 | 58.33 | 70.14 | 19.59 |
Free Cash Flow Growth | -11.86% | - | - | -16.84% | 258.12% | - |
Free Cash Flow Per Share | 0.33 | 0.37 | -0.03 | 0.25 | 0.32 | 0.10 |
Gross Margin | 45.07% | 44.20% | 39.47% | 47.97% | 53.29% | 50.84% |
Operating Margin | 5.77% | 5.61% | -3.28% | 4.53% | 4.10% | -4.39% |
Profit Margin | 2.78% | 0.32% | 3.16% | 2.14% | 3.28% | -10.35% |
FCF Margin | 5.62% | 6.71% | -0.73% | 7.52% | 12.32% | 6.48% |
EBITDA | 184.79 | 172.25 | 42.11 | 95.93 | 78.51 | 25.42 |
EBITDA Margin | 12.53% | 12.30% | 4.58% | 12.36% | 13.80% | 8.41% |
EBIT | 85 | 78.49 | -30.2 | 35.16 | 23.31 | -13.29 |
EBIT Margin | 5.77% | 5.61% | -3.28% | 4.53% | 4.10% | -4.39% |
Effective Tax Rate | 1.49% | 15.94% | -223.58% | 14.67% | -6.56% | -22.77% |